FI833339A - Foerfarande foer framstaellning av farmakologiskt verksamma diazabicyklo-(3,3,1)-nonaner - Google Patents

Foerfarande foer framstaellning av farmakologiskt verksamma diazabicyklo-(3,3,1)-nonaner Download PDF

Info

Publication number
FI833339A
FI833339A FI833339A FI833339A FI833339A FI 833339 A FI833339 A FI 833339A FI 833339 A FI833339 A FI 833339A FI 833339 A FI833339 A FI 833339A FI 833339 A FI833339 A FI 833339A
Authority
FI
Finland
Prior art keywords
nonaner
diazabic
cycles
frequency requirement
pharmacological
Prior art date
Application number
FI833339A
Other languages
English (en)
Other versions
FI76338C (fi
FI833339A0 (fi
FI76338B (fi
Inventor
Uwe Schoen
Bernd Hachmeister
Wolfgang Kehrbach
Ulrich Kyhl
Gerd Buschmann
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of FI833339A0 publication Critical patent/FI833339A0/fi
Publication of FI833339A publication Critical patent/FI833339A/fi
Application granted granted Critical
Publication of FI76338B publication Critical patent/FI76338B/fi
Publication of FI76338C publication Critical patent/FI76338C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI833339A 1982-09-18 1983-09-19 Foerfarande foer framstaellning av farmakologiskt verkande diazabicyklo-(3,3,1)-nonaner. FI76338C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane
DE3234697 1982-09-18

Publications (4)

Publication Number Publication Date
FI833339A0 FI833339A0 (fi) 1983-09-19
FI833339A true FI833339A (fi) 1984-03-19
FI76338B FI76338B (fi) 1988-06-30
FI76338C FI76338C (fi) 1988-10-10

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833339A FI76338C (fi) 1982-09-18 1983-09-19 Foerfarande foer framstaellning av farmakologiskt verkande diazabicyklo-(3,3,1)-nonaner.

Country Status (25)

Country Link
US (2) US4550112A (fi)
EP (2) EP0250903B1 (fi)
JP (2) JPS5970686A (fi)
AT (2) ATE69817T1 (fi)
AU (1) AU564910B2 (fi)
CA (1) CA1254209A (fi)
CS (1) CS389891A3 (fi)
DD (1) DD213923A5 (fi)
DE (3) DE3234697A1 (fi)
DK (1) DK165833C (fi)
ES (1) ES525653A0 (fi)
FI (1) FI76338C (fi)
GE (1) GEP19960316B (fi)
GR (1) GR78722B (fi)
HU (1) HU191096B (fi)
IE (1) IE57580B1 (fi)
IL (1) IL69751A (fi)
MX (1) MX9202996A (fi)
NO (1) NO160516C (fi)
NZ (1) NZ205627A (fi)
PH (1) PH20768A (fi)
PT (1) PT77344B (fi)
SU (1) SU1272989A3 (fi)
UA (1) UA817A1 (fi)
ZA (1) ZA836185B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) * 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
AU2004260624A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AR057064A1 (es) * 2005-06-13 2007-11-14 Astrazeneca Ab Compuestos para el tratamiento de arritmias cardiacas, formulacion farmaceutica y preparacion del compuesto
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (fi) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
NO160516B (no) 1989-01-16
DK165833B (da) 1993-01-25
DE3382466D1 (de) 1992-01-09
EP0250903A2 (de) 1988-01-07
ATE45579T1 (de) 1989-09-15
JPS5970686A (ja) 1984-04-21
DD213923A5 (de) 1984-09-26
US4550112A (en) 1985-10-29
ES8405398A1 (es) 1984-06-01
ATE69817T1 (de) 1991-12-15
JPH05247039A (ja) 1993-09-24
DK165833C (da) 1993-06-21
NO160516C (no) 1989-04-26
IE57580B1 (en) 1993-01-13
CA1254209A (en) 1989-05-16
IL69751A (en) 1986-10-31
EP0103833A3 (en) 1984-11-28
DK422583A (da) 1984-03-19
CA1259998C (fi) 1989-09-26
SU1272989A3 (ru) 1986-11-23
IE832186L (en) 1984-03-18
US4742172A (en) 1988-05-03
AU1920683A (en) 1984-03-22
NO833346L (no) 1984-03-19
IL69751A0 (en) 1983-12-30
NZ205627A (en) 1985-11-08
GEP19960316B (en) 1996-06-24
DE3380409D1 (de) 1989-09-21
UA817A1 (uk) 1993-12-15
AU564910B2 (en) 1987-09-03
GR78722B (fi) 1984-10-02
PH20768A (en) 1987-04-10
DE3234697A1 (de) 1984-03-22
PT77344A (en) 1983-10-01
ES525653A0 (es) 1984-06-01
PT77344B (en) 1986-03-11
FI76338C (fi) 1988-10-10
ZA836185B (en) 1984-04-25
EP0250903B1 (de) 1991-11-27
EP0250903A3 (en) 1988-03-09
EP0103833B1 (de) 1989-08-16
MX9202996A (es) 1992-07-01
FI833339A0 (fi) 1983-09-19
EP0103833A2 (de) 1984-03-28
JPH0670056B2 (ja) 1994-09-07
FI76338B (fi) 1988-06-30
CS389891A3 (en) 1992-07-15
HU191096B (en) 1987-01-28
DK422583D0 (da) 1983-09-16

Similar Documents

Publication Publication Date Title
FI833339A0 (fi) Foerfarande foer framstaellning av farmakologiskt verksamma diazabicyklo-(3,3,1)-nonaner
BG31499A3 (en) Method for obtaining of 1- vinyl- triazol derivatives
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
GR71207B (fi)
BG34907A3 (en) Method for preparing benzodiazepine compounds
ZA803818B (en) New 1-alka-2,4-dienyl-2-hydroxymethyl-3,4,5-trihydroxypipeidine compounds, the production and their medicinal use
BG35746A3 (en) Method for preparing 1- cyclohexenylmethylpyrolidines
FI822099A0 (fi) Maettade aminocyklitderivat, deras framstaellning och dessa innehaollande laekemedel
DE3561815D1 (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, process for their preparation and pharmaceutical compositions containing them
NO872574L (no) FremgangsmŸte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
BG35896A3 (en) Method for preparing 3- halogen- 3- cephem compounds
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
BG36633A3 (en) Method for preparing 3- hydroxycephalosporines
BG41128A3 (en) Method for prepparing intermediary compounds for preparation of benzothiazine- carboxamides
IT8023890A0 (it) Procedimento di preparazione di particelle solide di bisfenolo-f.
MX9101659A (es) Derivados de ergolina, proceso para su produccion y composicion farmaceutica que los contiene.
ES457552A1 (es) Procedimiento para la preparacion de aminoalcoxi-cicloalca- nos.
BG32565A3 (en) Method for producing of aminesubstituated 4, 5, 6, 7- tetrokhidro- 1h- (or 2h)- indazol

Legal Events

Date Code Title Description
TC Name/ company changed in patent

Owner name: SOLVAY PHARMACEUTICALS GMBH

MA Patent expired

Owner name: SOLVAY PHARMACEUTICALS GMBH